December 2024- Duke Health announced that the health care system has signed an asset purchase agreement to acquire Lake Norman Regional Medical Center (LNRMC) and the related businesses, in Mooresville, N.C. United States, from subsidiaries of Community Health Systems, Inc.
“We recognize the health care landscape is changing,” Craig Albanese, chief executive officer of Duke University Health System (DUHS). “While we continue to expand access to care within the communities we serve, it’s also time to do more and deliver care to more people – in more communities. We want to bring access to all that Duke Health has to offer to the Lake Norman community.”
With a projected closing in the first quarter of 2025, Duke’s acquisition of the 123-bed, acute-care hospital would represent a significant expansion of Duke Health clinical services outside the greater Triangle area.
While still early in the process, both organizations are proceeding with the necessary transition planning activities to ensure that patients have seamless access to their LNRMC providers, clinics and facilities.
“We know providers and team members are key to the success of any health system,” said Richard Shannon, DUHS senior vice president and chief medical officer. “We are eager to support LNRMC providers and employees in their mission to deliver exceptional care and an exceptional patient experience.”
Also Read : American Mission Hospital in Bahrain joins Mayo Clinic Care Network
“We will further the Duke Health mission by meeting the evolving health needs of every community we serve in a compassionate, collaborative and cost-effective manner,” Shannon said.
“Our primary focus is on the well-being of our patients and the community,” Albanese said. “LNRMC has a long history as a highly successful medical center, which we look forward to learning from as we develop relationships with team members, providers and the community and work together to serve Iredell County.”
Kaufman Hall acted as the exclusive financial advisor to Duke Health. This transaction is subject to customary regulatory approvals and other closing conditions.
